Cardiosonic

Cardiosonic has developed a groundbreaking solution for endoluminal high-intensity ultrasound ablation. It has created a high-intensity, non-focused therapeutic ultrasound catheter and a remote tissue ablation control system for renal denervation to treat hypertension. The company has tested the TIVUSTM system in numerous laboratory and animal studies, and recently initiated a pilot human clinical trial.